Ftse Mib
35.415,38
0,28%
DAX
20.330,56
0,06%
S&P 500
5.918,25
0,00%
NASDAQ
19.478,88
0,00%
Bitcoin
94.965,40
2,76%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ INVO BioScience Inc (INVO) INVO BioScience Inc (INVO) Notizie

INVO

INVO BioScience (INVO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INVO
DataOraFonteTitoloSimboloCompagnia
24/10/202415:00GlobeNewswire Inc.NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular CarcinomaNASDAQ:INVOINVO BioScience Inc
22/10/202418:05Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:INVOINVO BioScience Inc
21/10/202415:00GlobeNewswire Inc.INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA BiosciencesNASDAQ:INVOINVO BioScience Inc
15/10/202415:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
14/10/202415:18GlobeNewswire Inc.INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)NASDAQ:INVOINVO BioScience Inc
14/08/202415:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVOINVO BioScience Inc
14/08/202415:00GlobeNewswire Inc.INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDANASDAQ:INVOINVO BioScience Inc
21/05/202422:39Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INVOINVO BioScience Inc
15/05/202422:15GlobeNewswire Inc.INVO Reports Record First Quarter 2024 Financial ResultsNASDAQ:INVOINVO BioScience Inc
17/04/202416:25AllPennyStocks.comMicro Cap Massively Bid Up Before Opening BellNASDAQ:INVOINVO BioScience Inc
16/04/202422:59GlobeNewswire Inc.INVO Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:INVOINVO BioScience Inc
06/02/202416:24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVOINVO BioScience Inc
23/01/202414:00GlobeNewswire Inc.NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)NASDAQ:INVOINVO BioScience Inc
17/01/202414:00GlobeNewswire Inc.INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board DirectorsNASDAQ:INVOINVO BioScience Inc
16/01/202423:29Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:INVOINVO BioScience Inc
10/01/202422:46Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:INVOINVO BioScience Inc
28/12/202323:04Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:INVOINVO BioScience Inc
13/12/202323:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INVOINVO BioScience Inc
11/12/202314:00PR Newswire (US)NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood JournalNASDAQ:INVOINVO BioScience Inc
28/11/202315:00PR Newswire (US)INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity RequirementNASDAQ:INVOINVO BioScience Inc
24/11/202319:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INVOINVO BioScience Inc
13/11/202322:01PR Newswire (US)INVO Reports Record Third Quarter 2023 Financial ResultsNASDAQ:INVOINVO BioScience Inc
13/11/202315:23Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:INVOINVO BioScience Inc
13/11/202315:12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:INVOINVO BioScience Inc
10/11/202315:00PR Newswire (US)NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending MergerNASDAQ:INVOINVO BioScience Inc
09/11/202322:40PR Newswire (US)INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase WarrantsNASDAQ:INVOINVO BioScience Inc
27/10/202315:00PR Newswire (US)Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023NASDAQ:INVOINVO BioScience Inc
23/10/202313:30PR Newswire (US)INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science CompanyNASDAQ:INVOINVO BioScience Inc
11/10/202315:00PR Newswire (US)INVO to Participate in the Lytham Partners Fall 2023 Investor ConferenceNASDAQ:INVOINVO BioScience Inc
29/09/202322:05PR Newswire (US)INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERSNASDAQ:INVOINVO BioScience Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INVO

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
IVG
Iveco Group NV
BIT
LDO
Leonardo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
MONC
Moncler
BIT
TIT
Telecom Italia
BIT
PRY
Prysmian
BIT
RACE
Ferrari NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network